1. Diagnostic challenges in a patient with an occult insulinoma:68 Ga‐DOTA‐exendin‐4 PET/CT and 68Ga‐DOTATATE PET/CT
- Author
-
Nirupa Sachithanandan, Richard Norris, Elisa Bongetti, David A. Pattison, Rodney J. Hicks, Melissa H Lee, and Richard J MacIsaac
- Subjects
medicine.medical_specialty ,endocrine system ,Adenoma ,endocrine system diseases ,diagnostic imaging ,Nesidioblastosis ,030209 endocrinology & metabolism ,Case Report ,Case Reports ,insulinoma ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,medicine ,Medical imaging ,DOTA ,Insulinoma ,Endocrine gland neoplasm ,PET-CT ,business.industry ,pancreatic neoplasms ,General Medicine ,medicine.disease ,molecular imaging ,nesidioblastosis ,chemistry ,030220 oncology & carcinogenesis ,adenoma ,Islet cell ,Radiology ,Molecular imaging ,endocrine gland neoplasms ,business ,hormones, hormone substitutes, and hormone antagonists - Abstract
Key Clinical Message Despite growing evidence for GLP‐1R molecular‐based imaging, successful localization of insulinomas may require the use of multiple imaging modalities. Not all benign insulinomas express the GLP‐1R as expected. Our case demonstrates that there is a still an important role for traditional methods for the anatomical localization of an insulinoma.
- Published
- 2018